Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine PBMCs for repeated implantation failure
IRCT20241225064169N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of autologous G-CSF mobilized peripheral blood mononuclear cells in infertility and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Clinical pregnancy rate, Miscarriage rate and 2 more. Started Jan 2025; status: completed.
02
Drugs
autologous G-CSF mobilized peripheral blood mononuclear cells
03
Conditions
infertilityRecurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on IRCT20241225064169N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241225064169N1.